For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $0.40 in the prior trading day, Enviva Inc (NYSE: EVA) closed at $0.36, down -10.10%. In other words, the price has decreased by -$10.10 from its previous closing price. On the day, 0.87 million shares were traded. EVA stock price reached its highest trading level at $0.405 during the session, while it also had its lowest trading level at $0.355.
Ratios:
Our goal is to gain a better understanding of EVA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 6.23 whereas as Long-Term Debt/Eq ratio is at 6.18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 14 ’23 when INCLUSIVE CAPITAL PARTNERS, L. sold 2,250,000 shares for $1.49 per share. The transaction valued at 3,349,350 led to the insider holds 5,348,710 shares of the business.
BUMGARNER JOHN C JR bought 100,000 shares of EVA for $850,000 on May 25 ’23. The Director now owns 415,763 shares after completing the transaction at $8.50 per share. On May 19 ’23, another insider, BUMGARNER JOHN C JR, who serves as the Director of the company, bought 20,000 shares for $8.33 each. As a result, the insider paid 166,600 and bolstered with 315,763 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVA now has a Market Capitalization of 26453706 and an Enterprise Value of 1594367744. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.02 while its Price-to-Book (P/B) ratio in mrq is 0.09. Its current Enterprise Value per Revenue stands at 1.41 whereas that against EBITDA is 96.869.
Stock Price History:
Over the past 52 weeks, EVA has reached a high of $23.57, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -21.56%, while the 200-Day Moving Average is calculated to be -91.70%.
Shares Statistics:
The stock has traded on average 3.90M shares per day over the past 3-months and 570470 shares per day over the last 10 days, according to various share statistics. A total of 74.50M shares are outstanding, with a floating share count of 38.31M. Insiders hold about 48.57% of the company’s shares, while institutions hold 33.94% stake in the company. Shares short for EVA as of 1711584000 were 5380617 with a Short Ratio of 1.38, compared to 1709164800 on 8800711. Therefore, it implies a Short% of Shares Outstanding of 5380617 and a Short% of Float of 14.220000999999998.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 23.35.
Earnings Estimates
The company has Teva Pharmaceutical Industries analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $26.84, with high estimates of $25.34 and low estimates of $127.27.
